JP Morgan Private Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$594K	Sell	21,324 -1,270	-6%	-$41.5K	﹤0.01%	1174
2023 Q2	$770K	Sell	22,594 -6,240	-22%	-$196K	﹤0.01%	861
2023 Q1	$867K	Sell	28,834 -4,474	-13%	-$139K	﹤0.01%	1232
2022 Q4	$940K	Buy	33,308 +2,617	+9%	+$83.1K	﹤0.01%	1176
2022 Q3	$1.01M	Sell	30,691 -1,448	-5%	-$53.2K	﹤0.01%	1132
2022 Q2	$1.01M	Sell	32,139 -11,924	-27%	-$417K	﹤0.01%	1147
2022 Q1	$2.02M	Buy	44,063 +2,128	+5%	+$101K	﹤0.01%	891
2021 Q4	$2.57M	Sell	41,935 -32,683	-44%	-$2.26M	0.01%	813
2021 Q3	$5.58M	Buy	74,618 +8,971	+14%	+$753K	0.01%	563
2021 Q2	$6.07M	Buy	65,647 +49,112	+297%	+$4.18M	0.02%	536
2021 Q1	$1.47M	Buy	16,535 +13,259	+405%	+$1.32M	﹤0.01%	881
2020 Q4	$306K	Buy	+3,276	New	+$261K	﹤0.01%	1489

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ARKG Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its ARK Genomic Revolution ETF (ARKG) stake by 5.6% in Q3 2023, selling an estimated $41.5K and leaving 21,324 shares worth $594K. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

JP Morgan Private Wealth Advisors first reported a position in ARKG in Q4 2020 and has held it in 12 quarters since. The position peaked at $6.07M in Q2 2021. 288 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

JP Morgan Private Wealth Advisors held 21,324 shares of ARK Genomic Revolution ETF worth $594K as of Q3 2023.
JP Morgan Private Wealth Advisors sold 1,270 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $41.5K.
ARK Genomic Revolution ETF made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1174 holding.
JP Morgan Private Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 12 quarters since.
JP Morgan Private Wealth Advisors's ARK Genomic Revolution ETF position peaked at $6.07M in Q2 2021.
288 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.